Secukinumab in juvenile idiopathic arthritis–associated uveitis: results of open-label phase II study

Authors
Category Primary study
Conference33rd European Paediatric Rheumatology Congress
Year 2026
This article has no abstract
Epistemonikos ID: a359d54b774cb47d07093dfbfc3c76995a8c2e65
First added on: Oct 24, 2026